5-Year-Old Girl Battling Cancer Lives Her Dream in Disney Princess Photoshoot
The Woonsocket-based family was blown away by the photography results.
Arianna’s father, Ryan Taft, 32, told The Epoch Times that the journey so far has been “overwhelming,” both in terms of the little girl’s diagnosis and the outpouring of love and support the family has received.
Ryan said his daughter was diagnosed with aggressive kidney cancer in May this year. Arianna woke up with a softball-sized lump on her side one morning.
It turned out to be a 13-centimeter tumor on her kidney, both of which were successfully removed. But Arianna needed chemotherapy to target cancer that had already spread to her second kidney, lungs, liver, and lymph nodes. The little girl’s brave smile, prayer chains, and well-wishes helped ease the family’s heartbreak.
Emedgene collaborates with Illumina to scale the interpretation of genomic data for rare diseases
USA - English
News provided by
Share this article
Share this article
PALO ALTO, California, Dec. 16, 2020 /PRNewswire/ Emedgene, a leading precision medicine intelligence company, announces a non-exclusive partnership with
Illumina Inc. and the integration of automated interpretation into Illumina s TruSight™ Software Suite for rare genetic diseases. Emedgene s Clinical Rare Disease application is one of a portfolio of artificial intelligence (AI)-powered applications for high-throughput genomic interpretation across clinical and research use cases.
Healthcare is in the midst of a leap towards precision medicine. Continued improvements in the cost of next-generation sequencing (NGS) technologies, such as those developed by Illumina, have dramatically accelerated the adoption of genetic testing. Consequently, data generated from genomics doubles every year and is expected to